Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6448
|
pubmed:dateCreated |
1993-11-18
|
pubmed:abstractText |
High-density lipoprotein (HDL) contains two major proteins, apolipoprotein A-I (apoA-I) and apolipoprotein A-II (apoA-II), comprising about 70% and 20% of the total HDL protein mass, respectively. HDL exists in human plasma in two main forms, one containing apoA-I with apoA-II (AI/AII-HDL) and another containing apoA-I without apoA-II (AI-HDL). A strong inverse relationship exists between total plasma HDL concentration and atherosclerosis, but the results of studies examining the relationship between AI-HDL and AI/AII-HDL and atherosclerosis have been conflicting. To determine whether these two HDL populations have different effects on atherogenesis, human apoA-I (AI) and human apoA-I and apoA-II (AI/AII) transgenic mice were produced in an atherosclerosis-susceptible strain. Following an atherogenic diet, despite similar total cholesterol and HDL cholesterol concentrations, the area of atherogenic lesions in the AI/AII mice was 15-fold greater than in the AI animals. These studies show that the protein composition of HDL significantly affects its role in atherogenesis and that AI-HDL is more antiatherogenic than AI/AII-HDL.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0028-0836
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
21
|
pubmed:volume |
365
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
762-4
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8413656-Animals,
pubmed-meshheading:8413656-Apolipoprotein A-I,
pubmed-meshheading:8413656-Apolipoprotein A-II,
pubmed-meshheading:8413656-Arteriosclerosis,
pubmed-meshheading:8413656-Disease Susceptibility,
pubmed-meshheading:8413656-Female,
pubmed-meshheading:8413656-Humans,
pubmed-meshheading:8413656-Lipoproteins, HDL,
pubmed-meshheading:8413656-Male,
pubmed-meshheading:8413656-Mice,
pubmed-meshheading:8413656-Mice, Inbred C57BL,
pubmed-meshheading:8413656-Mice, Transgenic
|
pubmed:year |
1993
|
pubmed:articleTitle |
Protein composition determines the anti-atherogenic properties of HDL in transgenic mice.
|
pubmed:affiliation |
Life Sciences Division, Lawrence Berkeley Laboratory, University of California, Berkeley 94720.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|